Fri.Apr 25, 2025

article thumbnail

Declining Childhood Vaccinations Could Increase Frequency of Infectious Disease Previously Eliminated

Drug Topics

The findings support the need for improved vaccination coverage to prevent the resurgence of previously eliminated infectious diseases in the United States.

Vaccines 463
article thumbnail

STAT+: With the FDA in turmoil, the ‘revolving door’ with industry is spinning faster

STAT

Health and Human Services Secretary Robert F. Kennedy Jr. has railed against what he sees as a “revolving door” between workers at drug companies and the Food and Drug Administration. But his department’s actions now seem to be causing that door to spin ever faster.  Scores of FDA employees are searching for an exit from an agency in turmoil, particularly staff members tasked with reviewing drug applications, according to interviews with former employees and industry re

FDA 113
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What’s being cut at NIH

PharmaVoice

A look at the government’s far-reaching rollback in research grants so far.

245
245
article thumbnail

STAT+: Court ruling opens door to FDA action against Ozempic compounders

STAT

Novo Nordisk has notched a major legal win against compounding pharmacies that make copies of its diabetes and obesity drug semaglutide, sold under the brand names Ozempic and Wegovy. A federal judge on Thursday ruled against a compounding trade group’s request for a preliminary injunction that would have prevented the Food and Drug Administration from taking action against its members for making copies of semaglutide.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Philippe Masset appointed to Vect-Horus board of directors

Pharmafile

Vect-Horus has announced the appointment of Philippe Masset to the companys board of directors. This contributes to a series of senior leadership appointments which are strategic for Vect-Horus growth. Masset is a senior banking executive with a wealth of experience in investment banking, environmental, social and governance (ESG) topics, sustainable finance, and AI.

76
article thumbnail

What does Integrated Marketing Communications Mean in Pharma?

Pharma Marketing Network

Introduction In todays complex healthcare environment, what does it truly mean to practice Integrated Marketing Communications in pharma? For brands like Keytruda , Humira , and Ozempic , success isnt just about having a powerful product. Its about delivering consistent, engaging messages across a fragmented media landscape. Much like a symphony that requires every instrument to be in sync, pharma marketers must harmonize every touchpoint to resonate with both healthcare professionals and patien

More Trending

article thumbnail

STAT+: Pharmalittle: We’re reading about the FDA and revolving doors, a Novo win over compounders, and more

STAT

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up. We expect to promenade with the official mascots and catch up on our reading, but are, otherwise, open to suggestion. Of course, we do hope to hold another listening party, where the rotation will likely include this , this , this , this and this.

article thumbnail

Successful clinical outcomes for drug treating rare stroke condition

Pharmafile

Flemish biopharma company, Bioxodes, has announced promising results from the BIRCH phase 2a clinical trial of BIOX-101 to treat intracerebral haemorrhagic stroke (ICH). This brings the company closer to rolling out the first approved treatment for the devastating condition. The BIRCH trial, which took place with 16 patients with ICH, met both primary safety and […] The post Successful clinical outcomes for drug treating rare stroke condition appeared first on Pharmafile.

59
article thumbnail

From sound to science: How IP powers innovation in music and hearing

PhRMA

Every April 26th, World Intellectual Property (IP) Day marks a time to celebrate the creativity and innovation that fuel our economy. In 2025, the spotlight is on music—a universal language that connects people, culture and moments. But what if you couldn’t hear it? What if the joy of music was locked away, not by choice, but by biology?

144
144
article thumbnail

Could investigational drug become first-in-class bronchiectasis therapy?

European Pharmaceutical Review

The largest clinical trial investigating a treatment for bronchiectasis has demonstrated a statistically significant reduction in the occurrence of pulmonary exacerbations.Findings from the Phase III ASPEN study of brensocatib could provide future promise for patients, as there are currently no approved treatments for the chronic inflammatory pulmonary disease.

FDA 52
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

STAT+: Belgian antitrust regulator fines three companies $12.8 million over pharmacy displays

STAT

The Belgian antitrust regulator sanctioned some of the largest purveyors of over-the-counter medicines — Haleon, Kenvue, and Boehringer Ingelheim — the equivalent of $12.8 million for engaging in a long-running scheme that favored placement of their products in pharmacies. Known as category management arrangements, this involves using one or more companies allegedly conspiring to ensure their products receive favorable placement in stores.

58
article thumbnail

Does Referral Marketing Work in Pharma?

Pharma Marketing Network

Introduction In the age of digital disruption and evolving patient expectations, does Referral Marketing hold any real value in the pharmaceutical space? Think about this: when a friend recommends a restaurant, youre far more likely to try it. The same psychology applies in healthcare, though with significantly higher stakes. As pharma brands like Ozempic and Dupixent seek to establish deeper connections with prescribers and patients, referral-based strategies are increasingly being tested acros

HIPAA 52
article thumbnail

Q&A with 2025-26 Executive Fellows

PQA

The PQA Postdoctoral Executive Fellowship helps produce the next generation of leaders in health care quality through a full-time, 12-month program. Executive Fellows collaborate with PQA staff, members and other stakeholders on a variety of initiatives to improve medication use quality. During the fellowship, individuals will expand their skills and experience in project management, quality measure design and implementation, non-profit administration and association management, and health care

article thumbnail

How to Improve your Pharma Network

Pharma Marketing Network

Introduction In a rapidly evolving healthcare landscape, how can your Pharma Network stay ahead of the curve? As pharmaceutical brands face an unprecedented wave of digital transformation, strategic innovation, and shifting regulatory landscapes in 2025, optimizing your network has never been more critical. Much like upgrading an outdated GPS for an unknown journey, refreshing your pharma connections will determine whether your brand thrives or struggles in the new era.

HIPAA 52
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

STAT+: Up and down the ladder: The latest comings and goings

STAT

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

58
article thumbnail

Survey Respondents Report Dietary Modifications Help Relieve Endometriosis-Related Pain

Pharmacy Times

Although participants noted symptom relief, there was not a dietary modification uniquely perceived as beneficial.

102
102
article thumbnail

Ozempic patient blinded by NAION sues Novo Nordisk

pharmaphorum

Ozempic patient blinded by NAION sues Novo Nordisk Jonah.

100
100
article thumbnail

Recent Clinical Trial Highlights for NSCLC Treatment

Pharmacy Times

A panelist discusses how recent clinical trials for EGFR-positive nonsmall cell lung cancer (NSCLC) have expanded treatment options beyond single oral agents, with studies like FLAURA2, MARIPOSA, and PAPILLON demonstrating significant improvements in progression-free survival for combination therapies such as osimertinib plus chemotherapy and amivantamab plus lazertinib, though these combinations often come with higher rates of toxicity, discontinuation, and adverse effects compared to monothera

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

As concerns about infectious disease outbreaks increase, the HHS is facing a new lawsuit over $11B in grant terminations meant to curb epidemics.

88
article thumbnail

Integrating Clinical Trial Findings Into Everyday Pharmacy Practice

Pharmacy Times

A panelist discusses how combining therapies for EGFR-positive nonsmall cell lung cancer (NSCLC) increases both benefits (improved progression-free survival, response rates, and duration of response) and adverse effects, emphasizing that treatment selection should consider patient-specific factors like central nervous system (CNS) metastases, performance status, treatment aggressiveness preferences, and real-world limitations where patients often differ from clinical trial populations in terms o

65
article thumbnail

Akeso PD-1 inhibitor cleared as Keytruda challenger advances

pharmaphorum

Akeso has bagged an FDA approval for its PD-1 inhibitor penpulimab and reported new data on highly-touted PD-1/VEGF bispecific ivonescimab.

FDA 81
article thumbnail

Microcredentialing Opens New Doors for Pharmacy Technicians

Pharmacy Times

These short-term educational experiences can include specialized courses or training programs.

100
100
article thumbnail

FDA free to pursue semaglutide compounders after latest court ruling

Pharmaceutical Technology

Despite the decision being a win for Novo Nordisk, the compounded drugs sector is far too complex for this to be a final resolution.

article thumbnail

Asembia's AXS25 Summit: Must-See Sessions, Expert Interviews as Specialty Pharmacy Gathers

Pharmacy Times

The Asembia AXS25 Summit will include the latest news and expert insights in the specialty pharmacy field.

article thumbnail

Merck puts a price on its SpringWorks takeover bid

pharmaphorum

Merck KGaA has confirmed that talks to buy SpringWorks have advanced to the 'late-stage' and are revolving around an offer of around $47 per share

71
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Centene beat the Street on both profit and revenue in the first quarter of 2025, reporting $1.3 billion in earnings Friday morning.

69
article thumbnail

Fast-Tracking the Future

Pharmaceutical Commerce

Claire Riches highlights inefficiencies in the current drug approval process, while outlining the role of payers and insurers in shifting toward data-driven approval framework.

article thumbnail

AbbVie files fast-acting Botox successor in US

pharmaphorum

AbbVie is hoping to extend its range of neurotoxin-based pharma and cosmetic products with a short-acting successor to its blockbuster Botox brand.

66
article thumbnail

AAN 2025: Low-Sodium Oxybate Improves Sleep Quality, Daily Functioning in Narcolepsy, Idiopathic Hypersomnia

Pharmacy Times

Logan Schneider, MD, explains the latest findings on narcolepsy and idiopathic hypersomnia treatments, highlighting patient experiences and sleep architecture improvements.

65
article thumbnail

Granite Bio makes $100m debut, and other bio financings

pharmaphorum

Our round-up of recent biotech financings includes rounds for Granite Bio, Biolinq, Etiome, Grove Biopharma, and Synthetic Design Lab

64
article thumbnail

Pyrotinib-Based Therapy May Improve Survival in Patients With HER2+ Breast Cancer and Liver Metastases

Pharmacy Times

Pyrotinib is a tyrosine kinase inhibitor that is independently developed in China.

65
article thumbnail

Buyer’s remorse: The UK’s VPAG

pharmaphorum

Leela Barham takes stock of the debate surrounding the UKs current pricing and access deal that caps NHS spend on branded medicines, after a higher-than-expected payback rate for 2025.

52
article thumbnail

Many Patients With Elevated LDL Cholesterol Are Not Prescribed Lipid-Lowering Medication

Pharmacy Times

A significant number of patients with high low-density lipoprotein (LDL) cholesterol lack prescribed lipid-lowering medications, highlighting gaps in treatment and care practices.

65